Reducing nasal radiation for nasopharyngeal cancer
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This trial tests a new way to shape the radiation field for nasopharyngeal cancer that has spread into the nasal cavity. The goal is to reduce radiation to the nose while still effectively treating the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a newly diagnosed type of nasopharyngeal cancer called non-keratinizing carcinoma.
- The cancer must have spread into your nasal cavity (the space behind your nose), including the nasal septum.
- The cancer should be at an early or locally advanced stage (stages I to III), without any spread to distant organs.
- You must be between 18 and 70 years old and in generally good health (able to care for yourself).
- Your blood counts and liver/kidney function must be within acceptable ranges.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a lower dose of radiation to the standard dose for people with early-stage nasopharyngeal cancer. It aims to see if a lower dose is just as effective while reducing side effects.
This trial tests a new approach for people with nasopharyngeal cancer that has spread to lymph nodes in the neck after radiation. It uses careful evaluation and a special type of neck surgery to remove only the affected areas, hoping to reduce side effects and better control the cancer.
This trial tests whether intense radiation therapy (IMRT) alone is effective for people with stage IB nasopharyngeal carcinoma (a type of head and neck cancer) that has not spread to lower lymph nodes or formed large, matted nodes. If you qualify, you would receive targeted radiation without chemotherapy.
This trial tests whether a smaller radiation treatment area is as effective as the usual larger one for people whose metastatic nasopharyngeal cancer has responded well to first-line chemotherapy plus immunotherapy. It aims to reduce side effects while keeping the cancer under control.
This trial studies whether lowering the radiation dose to a smaller area around the tumor is safe and effective for people with newly diagnosed nasopharyngeal cancer that has not spread. It may reduce side effects while still curing the cancer.
This trial tests a new way to plan radiation treatment for nasopharyngeal cancer, where the target area is tailored to each patient's tumor spread. It aims to improve effectiveness while reducing side effects.
Hear when a new Nasopharyngeal Cancinoma (NPC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.